Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Hematology Am Soc Hematol Educ Program
Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth
Natural Production and Therapeutic Use Your body naturally produces some peptides, but therapeutic peptide protocols use synthetic versions designed to amplify these natural processes or address specific deficiencies
GLP-1 Receptor Pathway - Reduces hunger drive centrally (hypothalamus, brainstem) - Decreases the reward value of food (mesolimbic system) - Enhances glucose-dependent insulin secretion - Slows gastric emptying Amylin Receptor Pathway - Induces satiety through the area postrema and NTS - Activates POMC neurons (pro-satiety) and suppresses NPY/AgRP neurons (pro-hunger) in the arcuate nucleus - Additional gastric emptying delay through distinct neural circuits - Suppresses post-prandial glucagon secretion - May contribute to leptin resensitization The combination of these two pathways produces what researchers describe as broader modulation of neuroendocrine appetite control meaning amycretin hits more of the biological switches that drive eating behavior than a GLP-1-only drug can reach
US$ 23.86
US$ 20.20
US$ 24.01
